Explore our blog
FDA’s Plausible Mechanism Pathway: A Regulatory Shift with Significant Market Access Implications
Julia Wermerskirchen, Senior Director, Access Experience Team The FDA has introduced a new regulatory pathway — the...
Meet Our Access Experience Team: Julianna Kula, PharmD, BCOP
At Precision AQ, we know that navigating patient access challenges requires more than data—it takes real-world...
Risk-Sharing Contracts: Mainstream or Niche?
Kris Kang, VP, Access Experience Team